Peter Branagan

1.0k total citations
17 papers, 280 citations indexed

About

Peter Branagan is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases and Epidemiology. According to data from OpenAlex, Peter Branagan has authored 17 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Infectious Diseases and 3 papers in Epidemiology. Recurrent topics in Peter Branagan's work include Antifungal resistance and susceptibility (4 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers) and Cystic Fibrosis Research Advances (3 papers). Peter Branagan is often cited by papers focused on Antifungal resistance and susceptibility (4 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers) and Cystic Fibrosis Research Advances (3 papers). Peter Branagan collaborates with scholars based in Ireland, Australia and United Kingdom. Peter Branagan's co-authors include Noel G. McElvaney, Sanjay H. Chotirmall, Cedric Gunaratnam, Catherine M. Greene, Brian McCullagh, Michelle A. McMahon, P M Logan, Michael R. Watts, Oisin O’Connell and Kevin O′Regan and has published in prestigious journals such as Journal of the American Geriatrics Society, Thorax and British Journal of Clinical Pharmacology.

In The Last Decade

Peter Branagan

15 papers receiving 269 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Branagan Ireland 7 184 115 82 42 31 17 280
Marjeta Terčelj Slovenia 11 184 1.0× 37 0.3× 171 2.1× 36 0.9× 42 1.4× 35 371
Dan Sebastian Dîrzu Romania 6 46 0.3× 55 0.5× 25 0.3× 126 3.0× 13 0.4× 20 274
Lourdes R. Laraya-Cuasay United States 7 204 1.1× 28 0.2× 13 0.2× 81 1.9× 12 0.4× 13 276
Alice Castaldo Italy 11 149 0.8× 30 0.3× 20 0.2× 36 0.9× 19 0.6× 36 259
Hyeongtaek Woo South Korea 11 136 0.7× 28 0.2× 16 0.2× 51 1.2× 7 0.2× 20 337
Anissa Leonard Belgium 7 143 0.8× 50 0.4× 28 0.3× 64 1.5× 10 0.3× 8 219
Craig Jenkins Canada 12 51 0.3× 38 0.3× 114 1.4× 19 0.5× 21 0.7× 26 576
Arianna Biffi Italy 10 120 0.7× 47 0.4× 18 0.2× 85 2.0× 13 0.4× 21 263
Sadi Marcelo Schio Brazil 11 111 0.6× 78 0.7× 28 0.3× 102 2.4× 15 0.5× 21 273
D. Grenet France 8 156 0.8× 11 0.1× 54 0.7× 113 2.7× 11 0.4× 17 336

Countries citing papers authored by Peter Branagan

Since Specialization
Citations

This map shows the geographic impact of Peter Branagan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Branagan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Branagan more than expected).

Fields of papers citing papers by Peter Branagan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Branagan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Branagan. The network helps show where Peter Branagan may publish in the future.

Co-authorship network of co-authors of Peter Branagan

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Branagan. A scholar is included among the top collaborators of Peter Branagan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Branagan. Peter Branagan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
McElvaney, Oliver J., Brian Cleary, Oisín F. McElvaney, et al.. (2023). Safety and Reactogenicity of COVID-19 Vaccination in Severe Alpha-1 Antitrypsin Deficiency. Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation. 11(1). 3–12. 3 indexed citations
2.
McElvaney, Oliver J., Brian Cleary, Mark P. Murphy, et al.. (2022). Attitudes Towards Vaccination for Coronavirus Disease 2019 in Patients with Severe Alpha-1 Antitrypsin Deficiency. Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation. 9(2). 266–273. 2 indexed citations
3.
Toomey, Sinéad, Stephen F. Madden, Michelle Casey, et al.. (2020). Use of exhaled breath condensate (EBC) in the diagnosis of SARS-COV-2 (COVID-19). Thorax. 76(1). 86–88. 57 indexed citations
4.
Branagan, Peter, et al.. (2018). Finger Prick to Finger Tip: Use of Mobile Phone Technology to Send PKU Blood Results. Journal of Nutrition and Metabolism. 2018. 1–5. 1 indexed citations
5.
Branagan, Peter, Brendan Moran, Margaret Fitzgibbon, et al.. (2016). Inoculation site leprosy in a tattoo as a paradoxical reaction following tuberculosis treatment. The International Journal of Tuberculosis and Lung Disease. 20(5). 706–708. 4 indexed citations
6.
Branagan, Peter, Fiachra Moloney, Muhammad Haroon, et al.. (2015). Biomarkers to identify ILD and predict lung function decline in scleroderma lung disease or idiopathic pulmonary fibrosis.. PubMed. 32(3). 228–36. 36 indexed citations
7.
Branagan, Peter, Margaret Fitzgibbon, Máirín E. McMenamin, et al.. (2012). A Tale Of Two Mycobacteria. A2331–A2331.
8.
McMahon, Michelle A., Sanjay H. Chotirmall, Brian McCullagh, et al.. (2011). Radiological abnormalities associated with Aspergillus colonization in a cystic fibrosis population. European Journal of Radiology. 81(3). e197–e202. 49 indexed citations
9.
Chotirmall, Sanjay H., A. K. Mann, Peter Branagan, et al.. (2010). Male fertility in cystic fibrosis.. PubMed. 102(7). 204–6. 1 indexed citations
10.
Chotirmall, Sanjay H., et al.. (2009). Cystic fibrosis, common variable immunodeficiency and Aspergers syndrome: an immunological and behavioural challenge. Irish Journal of Medical Science (1971 -). 180(2). 607–609. 1 indexed citations
11.
Chotirmall, Sanjay H., et al.. (2009). Diagnosis and Management of Asthma in Older Adults. Journal of the American Geriatrics Society. 57(5). 901–909. 40 indexed citations
12.
Chotirmall, Sanjay H., Peter Branagan, Cedric Gunaratnam, & Noel G. McElvaney. (2008). Aspergillus/Allergic Bronchopulmonary Aspergillosis in an Irish Cystic Fibrosis Population: A Diagnostically Challenging Entity. Respiratory Care. 53(8). 1035–1041. 40 indexed citations
13.
Greene, Catherine M., Peter Branagan, & Noel G. McElvaney. (2008). Toll-like receptors as therapeutic targets in cystic fibrosis. Expert Opinion on Therapeutic Targets. 12(12). 1481–1495. 29 indexed citations
14.
Chotirmall, Sanjay H., et al.. (2006). 228 Prevalence of aspergillus/allergic bronchopulmonary aspergillosis in a CF population. Journal of Cystic Fibrosis. 5. S53–S53. 2 indexed citations
15.
MacMahon, B, et al.. (1985). Pharmacokinetics and haemodynamic effects of tocainide in patients with acute myocardial infarction complicated by left ventricular failure.. British Journal of Clinical Pharmacology. 19(4). 429–434. 13 indexed citations
16.
Drury, Ivo, Peter C. Hanley, Sean Blake, et al.. (1983). The diagnosis and treatment of constrictive pericarditis.. PubMed. 76(4). 171–2, 174. 1 indexed citations
17.
Branagan, Peter, Emily Saulitis Collins, & Luke Clancy. (1980). Aspergillosis in a chest hospital.. Irish Journal of Medical Science (1971 -). 149(12). 483–484. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026